When the federal authorities legalized non-medical cannabis in 2018, there have been — and proceed to be — many unknowns about its implications for mental and bodily health. Now, with the onset of COVID-19 and the corresponding improve in substance use, closing these data gaps has taken on new significance.
That’s why the Mental Health Commission of Canada (MHCC), in partnership with the Canadian Institutes of Health Research (CIHR), is happy to announce the funding of 4 staff grants to additional discover the relationship between mental health and cannabis use.
With a complete funding of practically $4.7 million over 5 years, the 4 analysis initiatives will delve deeper in the results of cannabis use in key areas, together with adolescent improvement, psychosis, autism spectrum dysfunction, and people that use forensic mental health providers. Detailed descriptions of every venture could be discovered on CIHR’s website.
The total goal of the initiatives is to analyze the potential harms and advantages of cannabis, the function of social determinants of health, and the wants of numerous populations experiencing cannabis use dysfunction and/or mental sickness.
The solely option to absolutely perceive what the legalization and regulation of cannabis means for individuals in Canada is to look more carefully into its results on particular populations, demographics, and issues. The MHCC believes that these grants symbolize a historic alternative to just do that, and we’re excited to be an element of it.
President and CEO, Mental Health Commission of Canada